CapsoVision, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $6.32
- 52-Week Range
- $4.38 – $15.37
- Market Cap
- $328.31M
- P/E (TTM)
- —
- EPS (TTM)
- -0.45
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 23.46
- PEG Ratio
- —
- Return on Equity
- -335.06%
- Return on Assets
- -132.47%
- Gross Margin
- 50.88%
- Operating Margin
- -208.07%
- Profit Margin
- -214.74%
- Current Ratio
- 3.35
- Debt/Equity
- 0.05
- Total Debt
- $687.00K
- Free Cash Flow
- $-16.28M
- Revenue Growth
- 9.90%
- Earnings Growth
- —
- Enterprise Value
- $300.40M
Market Snapshot
About
CapsoVision, Inc. is a medical device company specializing in capsule endoscopy technology for gastrointestinal diagnostics. Headquartered in Saratoga, California, the company manufactures and markets the CapsoCam Plus system, a wireless capsule camera that patients swallow to capture images of the small intestine. The device uses four cameras to provide 360-degree panoramic views, differentiating it from single-camera competitors. CapsoVision's technology is used by gastroenterologists to diagnose conditions such as Crohn's disease, gastrointestinal bleeding, and small bowel tumors.